The Immunology Core Facility (ICF) proposed for the Midwestern RCE currently serves the facultyat the University of Chicago by providing access to state-of-the-art immunological technologies andquantitative analytical approaches to measure molecular, cellular and tissue function. Forconsortium members, development of new immune-based therapies, such as vaccines and novelcytokines, requires careful monitoring of scientific endpoints to determine the optimal biologicallyactive dose and schedule of these agents. The ICF represents an established facility with expertisein handling human and mouse cells and tissues for the purpose of monitoring and evaluatingimmunological responses. This multi-parameter immunologic analysis will provide researchers withstate-of-the-art assays for determining the efficacy of pre-clinical and clinical therapies againsttargeted infectious agents. The ICF currently provides a wide variety of services and expertise toits users. For basic science research, the facility is utilized by researchers in many different areasof study for investigation of cellular structure/function, as well as for translational research in clinicalapplications and molecular medicine. The facility specializes in immunohistochemistry for cellulardetection within the context of the surrounding tissue, and generation and production of novelmonoclonal antibodies necessary for the detection of cells and subcellular components. The ICFalso has an expert flow cytometry group for the analytical detection and sorting of single cellsuspensions and subcellular components using multi-parameter fluorescence technology. Forclinical trials in human patients, the ICF performs assays to monitor immune responses. Thisservice enables clinical researchers to measure immunologic endpoints in participating studysubjects. The endpoint assays are primarily focused on human T cell responses, but include arange of other immunological readouts. Thus, the ICF can provide consortium members withexpert immunologic monitoring capabilities with which to carry out research and developmentalprojects.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
3U54AI057153-05S1
Application #
7700362
Study Section
Special Emphasis Panel (ZAI1-NBS-M (M2))
Project Start
2008-03-01
Project End
2009-02-28
Budget Start
2008-03-01
Budget End
2009-02-28
Support Year
5
Fiscal Year
2008
Total Cost
$196,494
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Hoang, Ky V; Rajaram, Murugesan V S; Curry, Heather Marie et al. (2018) Complement Receptor 3-Mediated Inhibition of Inflammasome Priming by Ras GTPase-Activating Protein During Francisella tularensis Phagocytosis by Human Mononuclear Phagocytes. Front Immunol 9:561
Mitchell, Anthony; Tam, Christina; Elli, Derek et al. (2017) Glutathionylation of Yersinia pestis LcrV and Its Effects on Plague Pathogenesis. MBio 8:
Chen, Grischa Y; McDougal, Courtney E; D'Antonio, Marc A et al. (2017) A Genetic Screen Reveals that Synthesis of 1,4-Dihydroxy-2-Naphthoate (DHNA), but Not Full-Length Menaquinone, Is Required for Listeria monocytogenes Cytosolic Survival. MBio 8:
Sloup, Rudolph E; Konal, Ashley E; Severin, Geoffrey B et al. (2017) Cyclic Di-GMP and VpsR Induce the Expression of Type II Secretion in Vibrio cholerae. J Bacteriol 199:
Kant, Sashi; Asthana, Shailendra; Missiakas, Dominique et al. (2017) A novel STK1-targeted small-molecule as an ""antibiotic resistance breaker"" against multidrug-resistant Staphylococcus aureus. Sci Rep 7:5067
Coulson, Garry B; Johnson, Benjamin K; Zheng, Huiqing et al. (2017) Targeting Mycobacterium tuberculosis Sensitivity to Thiol Stress at Acidic pH Kills the Bacterium and Potentiates Antibiotics. Cell Chem Biol 24:993-1004.e4
Hollands, Andrew; Corriden, Ross; Gysler, Gabriela et al. (2016) Natural Product Anacardic Acid from Cashew Nut Shells Stimulates Neutrophil Extracellular Trap Production and Bactericidal Activity. J Biol Chem 291:13964-73
Kuhn, Misty L; Alexander, Evan; Minasov, George et al. (2016) Structure of the Essential Mtb FadD32 Enzyme: A Promising Drug Target for Treating Tuberculosis. ACS Infect Dis 2:579-591
Duckworth, Benjamin P; Wilson, Daniel J; Aldrich, Courtney C (2016) Measurement of Nonribosomal Peptide Synthetase Adenylation Domain Activity Using a Continuous Hydroxylamine Release Assay. Methods Mol Biol 1401:53-61
Park, Sung Ryeol; Tripathi, Ashootosh; Wu, Jianfeng et al. (2016) Discovery of cahuitamycins as biofilm inhibitors derived from a convergent biosynthetic pathway. Nat Commun 7:10710

Showing the most recent 10 out of 516 publications